Global Macular Degeneration Drug Pipeline Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Macular Degeneration Drug Pipeline will have significant change from previous year. By the most conservative estimates of global Macular Degeneration Drug Pipeline market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Macular Degeneration Drug Pipeline market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Macular Degeneration Drug Pipeline market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Gene therapy
Small molecules
Stem cell therapy
Gene therapies
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Research Institute
Commercial
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen
Roche
Adverum Biotechnologies
AsclepiX Therapeutics
Bioeq AG
Sinocelltech
RemeGen
Grifols, S.A.
Kyowa Kirin
EyePoint Pharmaceutical
IVERIC Bio
Kodiak Sciences
Ribomic
Lineage Cell Therapeutics
Graybug Vision
CHABiotech
Shanghai Henlius Biotech
Bio-Thera Solutions
Alteogen
Outlook Therapeutics
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Macular Degeneration Drug Pipeline Market Size 2016-2026
2.1.2 Macular Degeneration Drug Pipeline Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Macular Degeneration Drug Pipeline Segment by Type
2.2.1 Gene therapy
2.2.2 Gene therapy
2.2.3 Stem cell therapy
2.2.4 Gene therapies
2.3 Macular Degeneration Drug Pipeline Market Size by Type
2.3.1 Global Macular Degeneration Drug Pipeline Market Size CAGR by Type
2.3.2 Global Macular Degeneration Drug Pipeline Market Size Market Share by Type (2016-2021)
2.4 Macular Degeneration Drug Pipeline Segment by Application
2.4.1 Hospital
2.4.2 Research Institute
2.4.3 Commercial
2.4.4 Other
2.5 Macular Degeneration Drug Pipeline Market Size by Application
2.5.1 Global Macular Degeneration Drug Pipeline Market Size CAGR by Application
2.5.2 Global Macular Degeneration Drug Pipeline Market Size Market Share by Application (2016-2021)
3 Macular Degeneration Drug Pipeline Market Size by Players
3.1 Macular Degeneration Drug Pipeline Market Size Market Share by Players
3.1.1 Global Macular Degeneration Drug Pipeline Revenue by Players (2019-2021E)
3.1.2 Global Macular Degeneration Drug Pipeline Revenue Market Share by Players (2019-2021E)
3.2 Global Macular Degeneration Drug Pipeline Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Macular Degeneration Drug Pipeline by Regions
4.1 Macular Degeneration Drug Pipeline Market Size by Regions (2016-2021)
4.2 Americas Macular Degeneration Drug Pipeline Market Size Growth (2016-2021)
4.3 APAC Macular Degeneration Drug Pipeline Market Size Growth (2016-2021)
4.4 Europe Macular Degeneration Drug Pipeline Market Size Growth (2016-2021)
4.5 Middle East & Africa Macular Degeneration Drug Pipeline Market Size Growth (2016-2021)
5 Americas
5.1 Americas Macular Degeneration Drug Pipeline Market Size by Country (2016-2021)
5.2 Americas Macular Degeneration Drug Pipeline Market Size by Type (2016-2021)
5.3 Americas Macular Degeneration Drug Pipeline Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Macular Degeneration Drug Pipeline Market Size by Region (2016-2021)
6.2 APAC Macular Degeneration Drug Pipeline Market Size by Type (2016-2021)
6.3 APAC Macular Degeneration Drug Pipeline Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Macular Degeneration Drug Pipeline by Country (2016-2021)
7.2 Europe Macular Degeneration Drug Pipeline Market Size by Type (2016-2021)
7.3 Europe Macular Degeneration Drug Pipeline Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Macular Degeneration Drug Pipeline by Region (2016-2021)
8.2 Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Type (2016-2021)
8.3 Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Macular Degeneration Drug Pipeline Market Forecast
10.1 Global Macular Degeneration Drug Pipeline Forecast by Regions (2021-2026)
10.1.1 Global Macular Degeneration Drug Pipeline Forecast by Regions (2021-2026)
10.1.2 Americas Macular Degeneration Drug Pipeline Forecast
10.1.3 APAC Macular Degeneration Drug Pipeline Forecast
10.1.4 Europe Macular Degeneration Drug Pipeline Forecast
10.1.5 Middle East & Africa Macular Degeneration Drug Pipeline Forecast
10.2 Americas Macular Degeneration Drug Pipeline Forecast by Countries (2021-2026)
10.2.1 United States Macular Degeneration Drug Pipeline Market Forecast
10.2.2 Canada Macular Degeneration Drug Pipeline Market Forecast
10.2.3 Mexico Macular Degeneration Drug Pipeline Market Forecast
10.2.4 Brazil Macular Degeneration Drug Pipeline Market Forecast
10.3 APAC Macular Degeneration Drug Pipeline Forecast by Region (2021-2026)
10.3.1 China Macular Degeneration Drug Pipeline Market Forecast
10.3.2 Japan Macular Degeneration Drug Pipeline Market Forecast
10.3.3 Korea Macular Degeneration Drug Pipeline Market Forecast
10.3.4 Southeast Asia Macular Degeneration Drug Pipeline Market Forecast
10.3.5 India Macular Degeneration Drug Pipeline Market Forecast
10.3.6 Australia Macular Degeneration Drug Pipeline Market Forecast
10.4 Europe Macular Degeneration Drug Pipeline Forecast by Country (2021-2026)
10.4.1 Germany Macular Degeneration Drug Pipeline Market Forecast
10.4.2 France Macular Degeneration Drug Pipeline Market Forecast
10.4.3 UK Macular Degeneration Drug Pipeline Market Forecast
10.4.4 Italy Macular Degeneration Drug Pipeline Market Forecast
10.4.5 Russia Macular Degeneration Drug Pipeline Market Forecast
10.5 Middle East & Africa Macular Degeneration Drug Pipeline Forecast by Region (2021-2026)
10.5.1 Egypt Macular Degeneration Drug Pipeline Market Forecast
10.5.2 South Africa Macular Degeneration Drug Pipeline Market Forecast
10.5.3 Israel Macular Degeneration Drug Pipeline Market Forecast
10.5.4 Turkey Macular Degeneration Drug Pipeline Market Forecast
10.5.5 GCC Countries Macular Degeneration Drug Pipeline Market Forecast
10.6 Global Macular Degeneration Drug Pipeline Forecast by Type (2021-2026)
10.7 Global Macular Degeneration Drug Pipeline Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Macular Degeneration Drug Pipeline Product Offered
11.1.3 Amgen Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Amgen Main Business Overview
11.1.5 Amgen Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Macular Degeneration Drug Pipeline Product Offered
11.2.3 Roche Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Adverum Biotechnologies
11.3.1 Adverum Biotechnologies Company Information
11.3.2 Adverum Biotechnologies Macular Degeneration Drug Pipeline Product Offered
11.3.3 Adverum Biotechnologies Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Adverum Biotechnologies Main Business Overview
11.3.5 Adverum Biotechnologies Latest Developments
11.4 AsclepiX Therapeutics
11.4.1 AsclepiX Therapeutics Company Information
11.4.2 AsclepiX Therapeutics Macular Degeneration Drug Pipeline Product Offered
11.4.3 AsclepiX Therapeutics Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 AsclepiX Therapeutics Main Business Overview
11.4.5 AsclepiX Therapeutics Latest Developments
11.5 Bioeq AG
11.5.1 Bioeq AG Company Information
11.5.2 Bioeq AG Macular Degeneration Drug Pipeline Product Offered
11.5.3 Bioeq AG Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Bioeq AG Main Business Overview
11.5.5 Bioeq AG Latest Developments
11.6 Sinocelltech
11.6.1 Sinocelltech Company Information
11.6.2 Sinocelltech Macular Degeneration Drug Pipeline Product Offered
11.6.3 Sinocelltech Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Sinocelltech Main Business Overview
11.6.5 Sinocelltech Latest Developments
11.7 RemeGen
11.7.1 RemeGen Company Information
11.7.2 RemeGen Macular Degeneration Drug Pipeline Product Offered
11.7.3 RemeGen Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 RemeGen Main Business Overview
11.7.5 RemeGen Latest Developments
11.8 Grifols, S.A.
11.8.1 Grifols, S.A. Company Information
11.8.2 Grifols, S.A. Macular Degeneration Drug Pipeline Product Offered
11.8.3 Grifols, S.A. Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Grifols, S.A. Main Business Overview
11.8.5 Grifols, S.A. Latest Developments
11.9 Kyowa Kirin
11.9.1 Kyowa Kirin Company Information
11.9.2 Kyowa Kirin Macular Degeneration Drug Pipeline Product Offered
11.9.3 Kyowa Kirin Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Kyowa Kirin Main Business Overview
11.9.5 Kyowa Kirin Latest Developments
11.10 EyePoint Pharmaceutical
11.10.1 EyePoint Pharmaceutical Company Information
11.10.2 EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Product Offered
11.10.3 EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 EyePoint Pharmaceutical Main Business Overview
11.10.5 EyePoint Pharmaceutical Latest Developments
11. IVERIC Bio
11.11.1 IVERIC Bio Company Information
11.11.2 IVERIC Bio Macular Degeneration Drug Pipeline Product Offered
11.11.3 IVERIC Bio Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 IVERIC Bio Main Business Overview
11.11.5 IVERIC Bio Latest Developments
11.12 Kodiak Sciences
11.12.1 Kodiak Sciences Company Information
11.12.2 Kodiak Sciences Macular Degeneration Drug Pipeline Product Offered
11.12.3 Kodiak Sciences Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Kodiak Sciences Main Business Overview
11.12.5 Kodiak Sciences Latest Developments
11.13 Ribomic
11.13.1 Ribomic Company Information
11.13.2 Ribomic Macular Degeneration Drug Pipeline Product Offered
11.13.3 Ribomic Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Ribomic Main Business Overview
11.13.5 Ribomic Latest Developments
11.14 Lineage Cell Therapeutics
11.14.1 Lineage Cell Therapeutics Company Information
11.14.2 Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Product Offered
11.14.3 Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Lineage Cell Therapeutics Main Business Overview
11.14.5 Lineage Cell Therapeutics Latest Developments
11.15 Graybug Vision
11.15.1 Graybug Vision Company Information
11.15.2 Graybug Vision Macular Degeneration Drug Pipeline Product Offered
11.15.3 Graybug Vision Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Graybug Vision Main Business Overview
11.15.5 Graybug Vision Latest Developments
11.16 CHABiotech
11.16.1 CHABiotech Company Information
11.16.2 CHABiotech Macular Degeneration Drug Pipeline Product Offered
11.16.3 CHABiotech Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 CHABiotech Main Business Overview
11.16.5 CHABiotech Latest Developments
11.17 Shanghai Henlius Biotech
11.17.1 Shanghai Henlius Biotech Company Information
11.17.2 Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Product Offered
11.17.3 Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Shanghai Henlius Biotech Main Business Overview
11.17.5 Shanghai Henlius Biotech Latest Developments
11.18 Bio-Thera Solutions
11.18.1 Bio-Thera Solutions Company Information
11.18.2 Bio-Thera Solutions Macular Degeneration Drug Pipeline Product Offered
11.18.3 Bio-Thera Solutions Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Bio-Thera Solutions Main Business Overview
11.18.5 Bio-Thera Solutions Latest Developments
11.19 Alteogen
11.19.1 Alteogen Company Information
11.19.2 Alteogen Macular Degeneration Drug Pipeline Product Offered
11.19.3 Alteogen Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Alteogen Main Business Overview
11.19.5 Alteogen Latest Developments
11.20 Outlook Therapeutics
11.20.1 Outlook Therapeutics Company Information
11.20.2 Outlook Therapeutics Macular Degeneration Drug Pipeline Product Offered
11.20.3 Outlook Therapeutics Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Outlook Therapeutics Main Business Overview
11.20.5 Outlook Therapeutics Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Macular Degeneration Drug Pipeline Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Gene therapy
Table 3. Major Players of Small molecules
Table 4. Major Players of Stem cell therapy
Table 5. Major Players of Gene therapies
Table 6. Macular Degeneration Drug Pipeline Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Macular Degeneration Drug Pipeline Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Macular Degeneration Drug Pipeline Market Size Market Share by Type (2016-2021)
Table 9. Macular Degeneration Drug Pipeline Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Macular Degeneration Drug Pipeline Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Macular Degeneration Drug Pipeline Market Size Market Share by Application (2016-2021)
Table 12. Global Macular Degeneration Drug Pipeline Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Macular Degeneration Drug Pipeline Revenue Market Share by Players (2019-2021E)
Table 14. Macular Degeneration Drug Pipeline Key Players Head office and Products Offered
Table 15. Macular Degeneration Drug Pipeline Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Macular Degeneration Drug Pipeline Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Macular Degeneration Drug Pipeline Market Size Market Share by Regions 2016-2021
Table 20. Americas Macular Degeneration Drug Pipeline Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Country (2016-2021)
Table 22. Americas Macular Degeneration Drug Pipeline Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Type (2016-2021)
Table 24. Americas Macular Degeneration Drug Pipeline Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Application (2016-2021)
Table 26. APAC Macular Degeneration Drug Pipeline Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Region (2016-2021)
Table 28. APAC Macular Degeneration Drug Pipeline Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Type (2016-2021)
Table 30. APAC Macular Degeneration Drug Pipeline Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Application (2016-2021)
Table 32. Europe Macular Degeneration Drug Pipeline Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Country (2016-2021)
Table 34. Europe Macular Degeneration Drug Pipeline Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Type (2016-2021)
Table 36. Europe Macular Degeneration Drug Pipeline Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Macular Degeneration Drug Pipeline
Table 45. Key Application and Potential Industries of Macular Degeneration Drug Pipeline
Table 46. Key Challenges of Macular Degeneration Drug Pipeline
Table 47. Key Trends of Macular Degeneration Drug Pipeline
Table 48. Global Macular Degeneration Drug Pipeline Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Macular Degeneration Drug Pipeline Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Macular Degeneration Drug Pipeline Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Macular Degeneration Drug Pipeline Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Macular Degeneration Drug Pipeline Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Macular Degeneration Drug Pipeline Market Size Market Share Forecast by Application (2021-2026)
Table 54. Amgen Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 55. Amgen Macular Degeneration Drug Pipeline Product Offered
Table 56. Amgen Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Amgen Main Business
Table 58. Amgen Latest Developments
Table 59. Roche Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 60. Roche Macular Degeneration Drug Pipeline Product Offered
Table 61. Roche Main Business
Table 62. Roche Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Roche Latest Developments
Table 64. Adverum Biotechnologies Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 65. Adverum Biotechnologies Macular Degeneration Drug Pipeline Product Offered
Table 66. Adverum Biotechnologies Main Business
Table 67. Adverum Biotechnologies Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Adverum Biotechnologies Latest Developments
Table 69. AsclepiX Therapeutics Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 70. AsclepiX Therapeutics Macular Degeneration Drug Pipeline Product Offered
Table 71. AsclepiX Therapeutics Main Business
Table 72. AsclepiX Therapeutics Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. AsclepiX Therapeutics Latest Developments
Table 74. Bioeq AG Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 75. Bioeq AG Macular Degeneration Drug Pipeline Product Offered
Table 76. Bioeq AG Main Business
Table 77. Bioeq AG Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Bioeq AG Latest Developments
Table 79. Sinocelltech Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 80. Sinocelltech Macular Degeneration Drug Pipeline Product Offered
Table 81. Sinocelltech Main Business
Table 82. Sinocelltech Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Sinocelltech Latest Developments
Table 84. RemeGen Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 85. RemeGen Macular Degeneration Drug Pipeline Product Offered
Table 86. RemeGen Main Business
Table 87. RemeGen Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. RemeGen Latest Developments
Table 89. Grifols, S.A. Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 90. Grifols, S.A. Macular Degeneration Drug Pipeline Product Offered
Table 91. Grifols, S.A. Main Business
Table 92. Grifols, S.A. Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Grifols, S.A. Latest Developments
Table 94. Kyowa Kirin Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 95. Kyowa Kirin Macular Degeneration Drug Pipeline Product Offered
Table 96. Kyowa Kirin Main Business
Table 97. Kyowa Kirin Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Kyowa Kirin Latest Developments
Table 99. EyePoint Pharmaceutical Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 100. EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Product Offered
Table 101. EyePoint Pharmaceutical Main Business
Table 102. EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. EyePoint Pharmaceutical Latest Developments
Table 104. IVERIC Bio Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 105. IVERIC Bio Macular Degeneration Drug Pipeline Product Offered
Table 106. IVERIC Bio Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. IVERIC Bio Main Business
Table 108. IVERIC Bio Latest Developments
Table 109. Kodiak Sciences Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 110. Kodiak Sciences Macular Degeneration Drug Pipeline Product Offered
Table 111. Kodiak Sciences Main Business
Table 112. Kodiak Sciences Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Kodiak Sciences Latest Developments
Table 114. Ribomic Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 115. Ribomic Macular Degeneration Drug Pipeline Product Offered
Table 116. Ribomic Main Business
Table 117. Ribomic Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. Ribomic Latest Developments
Table 119. Lineage Cell Therapeutics Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 120. Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Product Offered
Table 121. Lineage Cell Therapeutics Main Business
Table 122. Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. Lineage Cell Therapeutics Latest Developments
Table 124. Graybug Vision Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 125. Graybug Vision Macular Degeneration Drug Pipeline Product Offered
Table 126. Graybug Vision Main Business
Table 127. Graybug Vision Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. Graybug Vision Latest Developments
Table 129. CHABiotech Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 130. CHABiotech Macular Degeneration Drug Pipeline Product Offered
Table 131. CHABiotech Main Business
Table 132. CHABiotech Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. CHABiotech Latest Developments
Table 134. Shanghai Henlius Biotech Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 135. Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Product Offered
Table 136. Shanghai Henlius Biotech Main Business
Table 137. Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 138. Shanghai Henlius Biotech Latest Developments
Table 139. Bio-Thera Solutions Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 140. Bio-Thera Solutions Macular Degeneration Drug Pipeline Product Offered
Table 141. Bio-Thera Solutions Main Business
Table 142. Bio-Thera Solutions Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 143. Bio-Thera Solutions Latest Developments
Table 144. Alteogen Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 145. Alteogen Macular Degeneration Drug Pipeline Product Offered
Table 146. Alteogen Main Business
Table 147. Alteogen Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 148. Alteogen Latest Developments
Table 149. Outlook Therapeutics Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors
Table 150. Outlook Therapeutics Macular Degeneration Drug Pipeline Product Offered
Table 151. Outlook Therapeutics Main Business
Table 152. Outlook Therapeutics Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 153. Outlook Therapeutics Latest Developments
List of Figures
Figure 1. Macular Degeneration Drug Pipeline Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Macular Degeneration Drug Pipeline Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2020
Figure 7. Macular Degeneration Drug Pipeline in Hospital
Figure 8. Global Macular Degeneration Drug Pipeline Market: Hospital (2016-2021) & ($ Millions)
Figure 9. Macular Degeneration Drug Pipeline in Research Institute
Figure 10. Global Macular Degeneration Drug Pipeline Market: Research Institute (2016-2021) & ($ Millions)
Figure 11. Macular Degeneration Drug Pipeline in Commercial
Figure 12. Global Macular Degeneration Drug Pipeline Market: Commercial (2016-2021) & ($ Millions)
Figure 13. Macular Degeneration Drug Pipeline in Other
Figure 14. Global Macular Degeneration Drug Pipeline Market: Other (2016-2021) & ($ Millions)
Figure 15. Global Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2020
Figure 16. Global Macular Degeneration Drug Pipeline Revenue Market Share by Player in 2020
Figure 17. Global Macular Degeneration Drug Pipeline Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Macular Degeneration Drug Pipeline Market Size 2016-2021 ($ Millions)
Figure 19. APAC Macular Degeneration Drug Pipeline Market Size 2016-2021 ($ Millions)
Figure 20. Europe Macular Degeneration Drug Pipeline Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Macular Degeneration Drug Pipeline Market Size 2016-2021 ($ Millions)
Figure 22. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Country in 2020
Figure 23. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2020
Figure 24. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2020
Figure 25. United States Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Regions in 2020
Figure 29. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2020
Figure 30. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2020
Figure 31. China Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Country in 2020
Figure 38. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2020
Figure 39. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2020
Figure 40. Germany Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2020
Figure 48. Egypt Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Macular Degeneration Drug Pipeline Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 54. APAC Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 55. Europe Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 57. United States Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 58. Canada Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 61. China Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 62. Japan Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 63. Korea Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 65. India Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 66. Australia Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 67. Germany Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 68. France Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 69. UK Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 70. Italy Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 71. Russia Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 72. Spain Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 75. Israel Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Macular Degeneration Drug Pipeline Market Size 2021-2026 ($ Millions)
